Keyphrases
Blocking Antibodies
9%
Enhanced Liver Fibrosis
9%
HBV-HCV Coinfection
9%
Health Problems
9%
Highly Active Antiretroviral Therapy (HAART)
9%
HIV Infection
100%
HIV Patients
9%
HIV-1 Infection
9%
Human Immune System
18%
Human Liver Cells
9%
Human Liver Diseases
9%
Human-to-human
9%
Humanized Mouse Model
9%
IFNAR1
18%
Immune Defense
100%
Immunological Mechanisms
27%
Induced Mechanism
9%
Inflammation
9%
Liver Disease
100%
Liver Disease Models
9%
M2 Macrophages
9%
Macrophages
18%
New Therapeutics
9%
Novel Therapeutics
18%
Small Animal Model
9%
Viral Mechanisms
18%
Immunology and Microbiology
Blocking Antibody
6%
Coinfection
6%
Hepatitis B Virus
6%
Human Immunodeficiency Virus
100%
Human Immunodeficiency Virus 1
6%
Human Immunodeficiency Virus Infection
100%
Humanized Mouse
6%
Immune System
6%
Immunity
100%
Liver Cell
6%
M2 Macrophages
6%
Macrophage
13%
Mouse Model
6%